FDA Puts Cancer Risk Predictors into Safer Class II Category
Published Date: 8/21/2025
Rule
Summary
The FDA is officially putting cancer risk assessment systems into a safer, more controlled category called Class II. This means these devices will have special rules to make sure they work well and keep patients safe. This change helps people get better access to new, helpful tools without unnecessary delays or costs.
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Cancer Risk Tests Moved to Safer Category
The FDA is placing cancer predisposition risk assessment systems into Class II (special controls). The Agency says this classification provides a reasonable assurance of safety and effectiveness and will enhance patient access by reducing regulatory burdens for these devices.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in